meddevicedb.com FDA Device Reference

AP-3000 BLOOD GLUCOSE MONITORING SYSTEM, MAJOR GLUCOSE CONTROL SOLUTION

K103230 Class II Traditional
Decision Date
2012-04-24
Sponsor / Applicant
Bestgen Biotech Corp.

Technical Specification

510(k) Submission ID K103230
Product Code CGA
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1345
Decision Date 2012-04-24
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

AP-3000 BLOOD GLUCOSE MONITORING SYSTEM, MAJOR GLUCOSE CONTROL SOLUTION received FDA 510(k) clearance under submission number K103230, sponsored by Bestgen Biotech Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2012-04-24.

Classification & Regulation

This clearance is catalogued under FDA product code CGA and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.